@article{TCR9529,
author = {Fabrice Barlesi and Jean-Charles Soria and Dominique Maraninchi and Norbert Ifrah and Denis Moro-Sibilot},
title = {Biomarkers France: a first and distinctive step in assessing the impact of non-small cell lung cancer (NSCLC) patients routine molecular profiling},
journal = {Translational Cancer Research},
volume = {5},
number = {Suppl 3},
year = {2016},
keywords = {},
abstract = {The French Cooperative Thoracic Intergroup (IFCT) recently published the results of the Biomarkers France study, the largest nationwide program of molecular profiling for non-small cell lung cancer (NSCLC) patients (1). As highlighted in the three editorials published by Translational Cancer Research regarding these results, the Biomarkers France study not only shows that a routine molecular profiling is already feasible for all of our advanced NSCLC patients, but also that identification of a molecular alteration changes their outcomes by decreasing their risk of death by 22%.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/9529}
}